HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
Budhi Singh YadavDivya DahiyaP KannanShikha GoyalIshita LaroiyaSanthosh IrrinkiNgangom Robert SinghReena SharmaPublished in: Trials (2024)
The trial is registered with ClinicalTrials.gov ID NCT04472845 and CTRI with REF/2020/09/037050.